BIOMAT Database Logo BIOMAT Database Logo

Discovery of novel N-(1-benzyl-1H-imidazol-2-yl)amide derivatives as melanocortin 1 receptor agonists. 2022

Atsushi Sato, and Ritsuo Imashiro, and Hidekazu Tsujishima, and Kouichi Tanimoto, and Masahiko Miyashiro, and Hiroaki Chiba, and Masahiro Kondo, and Yasuo Yamamoto
Sohyaku, Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama 227-0033, Japan. Electronic address: satou.atsushi@mu.mt-pharma.co.jp.

Melanocortin-1 receptor (MC1R) is primarily activated by α-melanocyte-stimulating hormone (α-MSH) and plays a crucial role, such as keeping homeostasis in the skin against melanogenesis and external stimuli, anti-inflammatory effects, and tissue fibrosis suppression. Afamelanotide, an α-MSH analog MC1R agonist, is clinically used for treating erythroblastic protoporphyria (EPP) by subcutaneous implantation administration. Therefore, we initiated an investigation aimed at orally available small molecule nonpeptide MC1R agonists. Optimization from the internal hit compound 6a finally resulted in the discovery of N-(1-benzyl-1H-imidazol-2-yl)amide derivative 9g bearing isonipecotinic acid moiety, which demonstrated good MC1R agonistic activity and metabolic stability.

UI MeSH Term Description Entries
D004900 Erythroblasts Immature, nucleated ERYTHROCYTES occupying the stage of ERYTHROPOIESIS that follows formation of ERYTHROID PRECURSOR CELLS and precedes formation of RETICULOCYTES. The normal series is called normoblasts. Cells called MEGALOBLASTS are a pathologic series of erythroblasts. Erythrocytes, Nucleated,Normoblasts,Proerythroblasts,Pronormoblasts,Erythroblast,Erythrocyte, Nucleated,Normoblast,Nucleated Erythrocyte,Nucleated Erythrocytes,Proerythroblast,Pronormoblast
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D000521 alpha-MSH A 13-amino acid peptide derived from proteolytic cleavage of ADRENOCORTICOTROPIC HORMONE, the N-terminal segment of ACTH. ACTH (1-13) is amidated at the C-terminal to form ACTH (1-13)NH2 which in turn is acetylated to form alpha-MSH in the secretory granules. Alpha-MSH stimulates the synthesis and distribution of MELANIN in MELANOCYTES in mammals and MELANOPHORES in lower vertebrates. MSH, alpha,alpha Intermedin,alpha-Melanocyte-Stimulating Hormone,(Des-Acetyl)-alpha-MSH,(Desacetyl)alpha-MSH,ACTH (1-13),ACTH (1-13)NH2,ACTH(1-13),Acetylated ACTH (1-13)NH2,Adrenocorticotropin (1-13)NH2,DE-alpha-MSH,Des-Acetyl MSH,Desacetyl alpha-MSH,Desacetyl alpha-Melanocyte-Stimulating Hormone,MSH, (Desacetyl)alpha-,alpha-Melanotropin,Desacetyl alpha MSH,Desacetyl alpha Melanocyte Stimulating Hormone,Hormone, Desacetyl alpha-Melanocyte-Stimulating,Hormone, alpha-Melanocyte-Stimulating,Intermedin, alpha,MSH, Des-Acetyl,alpha MSH,alpha Melanocyte Stimulating Hormone,alpha Melanotropin,alpha-MSH, Desacetyl,alpha-Melanocyte-Stimulating Hormone, Desacetyl
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D044102 Receptor, Melanocortin, Type 1 A melanocortin receptor subtype found primarily in MELANOCYTES. It shows specificity for ALPHA-MSH and ADRENOCORTICOTROPIC HORMONE. Loss of function mutations of the type 1 melanocortin receptor account for the majority of red hair and fair skin recessive traits in human. Melanocortin Receptor 1,MC1 Receptor,Melanocortin-1 Receptor,Melanocyte Melanocortin Receptor,Receptor, Melanocortin-1,Melanocortin 1 Receptor,Melanocortin Receptor, Melanocyte,Receptor 1, Melanocortin,Receptor, MC1,Receptor, Melanocortin 1,Receptor, Melanocyte Melanocortin

Related Publications

Atsushi Sato, and Ritsuo Imashiro, and Hidekazu Tsujishima, and Kouichi Tanimoto, and Masahiko Miyashiro, and Hiroaki Chiba, and Masahiro Kondo, and Yasuo Yamamoto
Discovery of substituted (4-phenyl-1H-imidazol-2-yl)methanamine as potent somatostatin receptor 3 agonists.
September 2015, Bioorganic & medicinal chemistry letters,
Atsushi Sato, and Ritsuo Imashiro, and Hidekazu Tsujishima, and Kouichi Tanimoto, and Masahiko Miyashiro, and Hiroaki Chiba, and Masahiro Kondo, and Yasuo Yamamoto
Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
September 2014, European journal of medicinal chemistry,
Atsushi Sato, and Ritsuo Imashiro, and Hidekazu Tsujishima, and Kouichi Tanimoto, and Masahiko Miyashiro, and Hiroaki Chiba, and Masahiro Kondo, and Yasuo Yamamoto
Discovery of novel 1H-imidazol-2-yl-pyrimidine-4,6-diamines as potential antimalarials.
July 2010, Bioorganic & medicinal chemistry letters,
Atsushi Sato, and Ritsuo Imashiro, and Hidekazu Tsujishima, and Kouichi Tanimoto, and Masahiko Miyashiro, and Hiroaki Chiba, and Masahiro Kondo, and Yasuo Yamamoto
Synthesis and antiprotozoal activity of novel 2-{[2-(1H-imidazol-1-yl)ethyl]sulfanyl}-1H-benzimidazole derivatives.
July 2013, Bioorganic & medicinal chemistry letters,
Atsushi Sato, and Ritsuo Imashiro, and Hidekazu Tsujishima, and Kouichi Tanimoto, and Masahiko Miyashiro, and Hiroaki Chiba, and Masahiro Kondo, and Yasuo Yamamoto
(E)-N'-(4-Meth-oxy-benzyl-idene)-2-(2-methyl-4-nitro-1H-imidazol-1-yl)acetohydrazide.
October 2012, Acta crystallographica. Section E, Structure reports online,
Atsushi Sato, and Ritsuo Imashiro, and Hidekazu Tsujishima, and Kouichi Tanimoto, and Masahiko Miyashiro, and Hiroaki Chiba, and Masahiro Kondo, and Yasuo Yamamoto
Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonists.
October 2011, Journal of medicinal chemistry,
Atsushi Sato, and Ritsuo Imashiro, and Hidekazu Tsujishima, and Kouichi Tanimoto, and Masahiko Miyashiro, and Hiroaki Chiba, and Masahiro Kondo, and Yasuo Yamamoto
4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives, a novel class of selective delta-opioid agonists.
January 2006, Bioorganic & medicinal chemistry letters,
Atsushi Sato, and Ritsuo Imashiro, and Hidekazu Tsujishima, and Kouichi Tanimoto, and Masahiko Miyashiro, and Hiroaki Chiba, and Masahiro Kondo, and Yasuo Yamamoto
1,2-Bis[4-(1H-imidazol-1-yl)benzyl-idene]hydrazine.
June 2012, Acta crystallographica. Section E, Structure reports online,
Atsushi Sato, and Ritsuo Imashiro, and Hidekazu Tsujishima, and Kouichi Tanimoto, and Masahiko Miyashiro, and Hiroaki Chiba, and Masahiro Kondo, and Yasuo Yamamoto
2-[2-(1H-Imidazol-1-yl)-2-adamant-yl]phenol.
January 2011, Acta crystallographica. Section E, Structure reports online,
Atsushi Sato, and Ritsuo Imashiro, and Hidekazu Tsujishima, and Kouichi Tanimoto, and Masahiko Miyashiro, and Hiroaki Chiba, and Masahiro Kondo, and Yasuo Yamamoto
trans-Bis[1-(2-anilino-2-oxoeth-yl)-3-benzyl-1H-imidazol-2-yl]palladium(II) methanol disolvate.
April 2011, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!